KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Receivables - Other (2020 - 2023)

Pfizer has reported Receivables - Other over the past 8 years, most recently at $57.0 million for Q2 2023.

  • Quarterly Receivables - Other fell 57.14% to $57.0 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $57.0 million through Apr 2023, down 57.14% year-over-year, with the annual reading at $53.0 million for FY2021, 86.78% down from the prior year.
  • Receivables - Other was $57.0 million for Q2 2023 at Pfizer, down from $167.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $871.0 million in Q2 2021 and troughed at $53.0 million in Q4 2021.
  • The 4-year median for Receivables - Other is $197.0 million (2021), against an average of $287.2 million.
  • Year-over-year, Receivables - Other plummeted 86.78% in 2021 and then fell 15.23% in 2022.
  • A 4-year view of Receivables - Other shows it stood at $401.0 million in 2020, then plummeted by 86.78% to $53.0 million in 2021, then soared by 215.09% to $167.0 million in 2022, then crashed by 65.87% to $57.0 million in 2023.
  • Per Business Quant, the three most recent readings for PFE's Receivables - Other are $57.0 million (Q2 2023), $167.0 million (Q4 2022), and $272.0 million (Q3 2022).